| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 149 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 111 |
| 2 | TACROLIMUS OINTMENT 0.1% | 110 |
| 3 | MYCOPHENOLATE MOFETIL | 96 |
| 4 | PREDNISONE | 61 |
| 5 | MYCOPHENOLIC ACID | 34 |
| 6 | PREDNISOLONE | 34 |
| 7 | PREDNISOLONE ORAL | 34 |
| 8 | PREDNISOLONE ORAL SOLUTION | 34 |
| 9 | METHYLPREDNISOLONE | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRENATAL WITH FERROUS FUMARATE AND FOLIC ACID | 1 | 0.5000 |
| 1 | NITAZOXANIDE | 1 | 0.0029 |
| 2 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 23 | 0.0028 |
| 3 | INTERLEUKIN-10 | 1 | 0.0028 |
| 4 | MYCOPHENILIC ACID | 25 | 0.0012 |
| 5 | VALGANCICLOVIR | 20 | 0.0010 |
| 6 | MYCOPHENOLIC ACID | 34 | 0.0010 |
| 7 | TACROLIMUS | 149 | 0.0009 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 111 | 0.0009 |
| 9 | TACROLIMUS OINTMENT 0.1% | 110 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 102 |
| 1 | Insulin Analog [EPC] | 28 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 25 |
| 3 | Immunoglobulin G [EPC] | 23 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 19 |
| 5 | Azole Antifungal [EPC] | 18 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 |
| 7 | Polyene Antifungal [EPC] | 17 |
| 8 | Kinase Inhibitor [EPC] | 16 |
| 9 | mTOR Inhibitor Immunosuppressant [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 25 | 0.0012 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 | 0.0008 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 14 | 0.0007 |
| 3 | Polyene Antifungal [EPC] | 17 | 0.0004 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 19 | 0.0003 |
| 7 | Insulin [EPC] | 12 | 0.0003 |
| 8 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |